These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 11404826

  • 1. Use of exogenous estrogens in systemic lupus erythematosus.
    Mok CC, Lau CS, Wong RW.
    Semin Arthritis Rheum; 2001 Jun; 30(6):426-35. PubMed ID: 11404826
    [Abstract] [Full Text] [Related]

  • 2. [Estrogen use in systemic lupus erythematosus].
    Ketari S, Cherif O, Boussema F, Kochbati S, Ben Dhaou B, Rokbani L.
    Gynecol Obstet Fertil; 2005 Oct; 33(10):783-90. PubMed ID: 16139552
    [Abstract] [Full Text] [Related]

  • 3. The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus.
    Holroyd CR, Edwards CJ.
    Climacteric; 2009 Oct; 12(5):378-86. PubMed ID: 19591008
    [Abstract] [Full Text] [Related]

  • 4. [Hormonal therapy in systemic lupus erythematosus].
    Kaliterna DM, Krstulović DM, Radić M.
    Reumatizam; 2009 Oct; 56(2):41-3. PubMed ID: 20429261
    [Abstract] [Full Text] [Related]

  • 5. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A, Piette JC.
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
    Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS.
    Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
    [Abstract] [Full Text] [Related]

  • 11. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus.
    Meier CR, Sturkenboom MC, Cohen AS, Jick H.
    J Rheumatol; 1998 Aug; 25(8):1515-9. PubMed ID: 9712093
    [Abstract] [Full Text] [Related]

  • 12. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus.
    Buyon JP.
    J Am Med Womens Assoc (1972); 1998 Aug; 53(1):13-7. PubMed ID: 9458619
    [Abstract] [Full Text] [Related]

  • 13. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
    Bernatsky S, Clarke A, Ramsey-Goldman R, Joseph L, Boivin JF, Rajan R, Moore AD, Leung MH, Allen A, Gordon C.
    Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
    [Abstract] [Full Text] [Related]

  • 14. Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy.
    Petri M.
    Lupus; 2001 Sep; 10(3):222-6. PubMed ID: 11315357
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tibolone in postmenopausal women with systemic lupus erythematosus: a pilot study.
    Vieira CS, Pereira FV, de Sá MF, Paulo LJ, Martins WP, Ferriani RA.
    Maturitas; 2009 Mar 20; 62(3):311-6. PubMed ID: 19193505
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.